Presentation Information
[O3-01]JN.1型mRNAワクチン及び組換えタンパクワクチンブースター接種によるSARS-CoV-2オミクロン変異株に対する免疫原性の評価
*Yohei Seki1, Kiyoko Nojima1, Sayuri Sakuragi 1, Haruka Momose1, Wakako Kuribayashi1, Kei Miyakawa2, Shutoku Matsuyama3, Hideki Hasegawa2, Yasuo Yoshihara4, Takuo Mizukami1 (1. Center for Next-Generation Biologics Research, National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, 3. Department of Respiratory Viruses, National Institute of Infectious Diseases, Japan Institute for Health Security, 4. National Hospital Organization Murayama Medical Center)